+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Genetic Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 189 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904587
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The genetic testing market is rapidly transforming, presenting both opportunities and challenges for senior healthcare and diagnostics leaders. As technological innovation accelerates and demand grows, organizations need actionable intelligence to inform investment, operational planning, and competitive strategy.

Market Snapshot: Genetic Testing Market Growth Outlook

From 2025 to 2032, the genetic testing market is projected to expand significantly, with total market value rising from USD 15.44 billion to USD 39.72 billion at a CAGR of 14.44%. This sustained growth is fueled by higher adoption rates in both clinical and nonclinical environments. Core factors driving the market include continuous improvements in sequencing technologies, expanded informatics infrastructure, and a stronger emphasis on population-level health initiatives.

Scope & Segmentation of the Genetic Testing Market

The report presents a detailed view of the genetic testing market, segmenting risk and opportunity across the value chain for stakeholders seeking clarity on both demand and supply-side dynamics:

  • Product Categories: Consumables and equipment are integral for laboratory operations, requiring focused procurement and inventory planning. Software and services facilitate ongoing workflows and call for solutions with seamless integration.
  • Test Modalities: Carrier, diagnostic, newborn, prenatal, pharmacogenomics, presymptomatic and predictive, and preimplantation testing each introduce unique workflow, validation, and utility requirements that impact adoption and reimbursement.
  • Technology Platforms: Cytogenetics, microarrays, DNA sequencing, polymerase chain reaction (PCR), and gene expression profiling support evolving diagnostic and research protocols, necessitating careful assessment of integration strategies for both established and emerging tools.
  • Clinical & Nonclinical Applications: Rapid uptake in oncology and rare disease diagnostics, alongside increased use for chronic disease management and neurogenetics, highlights the need for robust data infrastructure and validated biomarkers.
  • Distribution Approaches: The market leverages both offline channels and direct-to-consumer digital models. Companies must balance laboratory distribution with growing demand for at-home testing solutions to reach diverse user groups.
  • End-User Settings: Diagnostic laboratories, hospitals and clinics, and home-based settings present different product strategy requirements and adoption drivers, influenced by provider workflows and patient accessibility.
  • Regions Covered: Americas, Europe, Middle East & Africa, and Asia-Pacific all feature distinct regulatory, funding, and market maturity profiles that shape timelines and operational approaches for delivering genetic testing services.

Key Takeaways for Decision-Makers

  • Adoption of advanced genetic testing technologies is driving efficiency and broadening access, but integration with established clinical and payer systems is essential to sustain growth.
  • Generating real-world evidence to establish clinical utility is increasingly critical as regulators and payers heighten scrutiny and value-based frameworks are prioritized.
  • Consumer interest in at-home and direct-to-consumer testing solutions is rising, while healthcare providers emphasize the need for validated and actionable outcomes to satisfy clinical and patient objectives.
  • Ongoing supply chain pressures, including tariffs, are prompting organizations to diversify procurement sources and invest in responsive supply chain management strategies to maintain product stability and cost-effectiveness.
  • Regional differences, such as fragmented reimbursement models or expanding laboratory capacity, require tailored go-to-market and investment strategies to address specific local market challenges and opportunities.
  • Investment in interoperability, robust privacy systems, and strong data governance is paramount to building trust, ensuring compliance, and enabling integration of testing solutions into new healthcare environments.

Tariff Impact: Navigating Trade and Supply Chain Shifts

Recent U.S. tariff measures have introduced additional cost considerations along the genetic testing supply chain. Higher landed costs for critical equipment and consumables are impacting operational margins and prompting manufacturers to revisit procurement strategies. Many market participants are prioritizing regional manufacturing and strengthening local supplier relationships to reinforce supply chain resilience and limit exposure to disruption.

These supply chain adjustments are affecting access for both patients and providers, particularly in resource-constrained settings. To ensure affordability and reliability, stakeholders are increasing collaboration with suppliers, adopting scenario-based operational planning, and advocating for procurement policies that optimize cost management in an evolving trade environment.

Methodology & Data Sources

This report combines quantitative and qualitative market research. Direct feedback from clinical leaders, laboratory management, and payers is integrated with comprehensive secondary research and regulatory reviews. All findings undergo triangulation and validation by industry experts.

Why This Report Matters

  • Equips executives with the insights needed to align innovation and regulatory developments with new business models and operational priorities.
  • Delivers actionable intelligence for procurement, clinical, and commercial teams by detailing risks and opportunities across key product categories, application areas, and regions.
  • Supports resilient decision-making with scenario analyses and real-time perspectives from leading market stakeholders.

Conclusion

Comprehensive analysis of technology advancements, regulatory change, and operational factors positions leaders to realize both clinical and commercial objectives in the evolving genetic testing landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Genetic Testing Market, by Product
8.1. Consumables & Equipment
8.2. Software & Services
9. Genetic Testing Market, by Test Type
9.1. Carrier Testing
9.2. Diagnostic Testing
9.3. New Born Screening
9.4. Pharmacogenomics
9.5. Preimplantation Testing
9.6. Prenatal Testing
9.7. Presymptomatic & Predictive Testing
10. Genetic Testing Market, by Technology
10.1. Cytogenetics
10.2. DNA Sequencing
10.3. Gene Expression Profiling
10.4. Microarrays
10.5. PCR
11. Genetic Testing Market, by Application
11.1. Autoimmune Disorders
11.2. Cancer
11.3. Chronic Diseases
11.4. Genetic Disorders
11.5. Neurodegenerative Diseases
12. Genetic Testing Market, by Distribution Channel
12.1. Offline
12.2. Online
13. Genetic Testing Market, by End-User
13.1. Diagnostic Laboratories
13.2. Home Setting
13.3. Hospitals & Clinics
14. Genetic Testing Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Genetic Testing Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Genetic Testing Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Genetic Testing Market
18. China Genetic Testing Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. Agilent Technologies, Inc.
19.7. Becton, Dickinson and Company
19.8. Bio-Rad Laboratories, Inc.
19.9. Bio-Techne Corporation
19.10. Bruker Corporation
19.11. Centogene N.V.
19.12. Color Health, Inc.
19.13. CooperSurgical Inc.
19.14. Editas Medicine, Inc.
19.15. Eugene Labs Pty Ltd.
19.16. Eurofins Scientific SE
19.17. F. Hoffmann-La Roche AG
19.18. Fulgent Genetics, Inc.
19.19. Gene by Gene, Ltd.
19.20. GeneDx, LLC
19.21. Illumina, Inc.
19.22. Invitae Corporation
19.23. Laboratory Corporation of America Holdings
19.24. Living DNA Ltd.
19.25. Macrogen, Inc.
19.26. MyHeritage Ltd.
19.27. Myriad Genetics, Inc.
19.28. Natera, Inc.
19.29. Newtopia Inc.
19.30. PathogenDx Corporation
19.31. PerkinElmer Inc.
19.32. Qiagen N.V.
19.33. Quest Diagnostics Incorporated
19.34. Sanofi S.A.
19.35. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL GENETIC TESTING MARKET SIZE, BY CONSUMABLES & EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL GENETIC TESTING MARKET SIZE, BY CONSUMABLES & EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL GENETIC TESTING MARKET SIZE, BY CONSUMABLES & EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL GENETIC TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL GENETIC TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL GENETIC TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC & PREDICTIVE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC & PREDICTIVE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC & PREDICTIVE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL GENETIC TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL GENETIC TESTING MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL GENETIC TESTING MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL GENETIC TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL GENETIC TESTING MARKET SIZE, BY CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL GENETIC TESTING MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL GENETIC TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GENETIC TESTING MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL GENETIC TESTING MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL GENETIC TESTING MARKET SIZE, BY HOME SETTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL GENETIC TESTING MARKET SIZE, BY HOME SETTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL GENETIC TESTING MARKET SIZE, BY HOME SETTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL GENETIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL GENETIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL GENETIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS GENETIC TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 109. EUROPE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. EUROPE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 111. EUROPE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 112. EUROPE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 113. EUROPE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 114. EUROPE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. EUROPE GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 123. AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. AFRICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 125. AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 126. AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 127. AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 129. AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. ASEAN GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. ASEAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 140. ASEAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 141. ASEAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 142. ASEAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. ASEAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 144. ASEAN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 145. GCC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GCC GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 147. GCC GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 148. GCC GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 149. GCC GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 150. GCC GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 151. GCC GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 159. BRICS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. BRICS GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 161. BRICS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 162. BRICS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 163. BRICS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 164. BRICS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 165. BRICS GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 166. G7 GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. G7 GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 168. G7 GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 169. G7 GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 170. G7 GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 171. G7 GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 172. G7 GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 173. NATO GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. NATO GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 175. NATO GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 176. NATO GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 177. NATO GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. NATO GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 179. NATO GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. UNITED STATES GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 182. UNITED STATES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 183. UNITED STATES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 184. UNITED STATES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 185. UNITED STATES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 186. UNITED STATES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 187. UNITED STATES GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 188. CHINA GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 189. CHINA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 190. CHINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 191. CHINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 192. CHINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 193. CHINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 194. CHINA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Genetic Testing market report include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Bruker Corporation
  • Centogene N.V.
  • Color Health, Inc.
  • CooperSurgical Inc.
  • Editas Medicine, Inc.
  • Eugene Labs Pty Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Fulgent Genetics, Inc.
  • Gene by Gene, Ltd.
  • GeneDx, LLC
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Living DNA Ltd.
  • Macrogen, Inc.
  • MyHeritage Ltd.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • Newtopia Inc.
  • PathogenDx Corporation
  • PerkinElmer Inc.
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • Sanofi S.A.
  • Thermo Fisher Scientific Inc.

Table Information